CFOTO | Future Publishing | Getty Images
The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased